Gene · 1459
Papers2,405
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,405
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Broadening the Okur-Chung syndrome phenotype: adult-onset metabolic features and a contiguous 20p13 deletion in a Turkish multicenter cohort. | J Hum Genet | 2026 | 42706398 | PubTator, text mining | PubMed |
| NatD promotes glioblastoma progression through epigenetic activation of FGFR4 signalling. | Exp Mol Med | 2026 | 42686986 | PubTator, text mining | PubMed |
| CSNK2A2 drives knee osteoarthritis progression by co-activating the Wnt/β-catenin and NF-κB signaling pathways. | Arch Biochem Biophys | 2026 | 42674201 | PubTator, text mining | PubMed |
| RAGE phosphorylation by CK2 in human epithelial cell model: Modulation of connexin 43 expression. | iScience | 2026 | 42621156 | PubTator, text mining | PubMed |
| Ambient PM2.5 exposure and sleep quality: Evidence from circadian DNA methylation signatures in a population-based study. | J Hazard Mater | 2026 | 42537304 | PubTator, text mining | PubMed |
| Discovery and characterization of a novel class of cyclic peptidic compounds inhibiting the subunit interaction of the protein kinase CK2α2β2 holoenzyme. | RSC Chem Biol | 2026 | 42433702 | PubTator, text mining | PubMed |
| FLOWR.ROOT - A flow matching-based foundation model for joint multi-purpose structure-aware 3D ligand generation and affinity prediction. | Nat Commun | 2026 | 42409794 | PubTator, text mining | PubMed |
| Blocking CK2α-Bclaf1 Preserves Oligodendrocytes After Neonatal Hypoxic Injury. | Glia | 2026 | 42388009 | PubTator, text mining | PubMed |
| Improved prognostic survival models for pediatric medulloblastoma using high dimensional gene expression data. | BMC Med Genomics | 2026 | 42387537 | PubTator, text mining | PubMed |
| Spatial Confinement-Accelerated DNAzyme Nanoassembly for Demethylase Imaging and Chemoresistance Evaluation in Living Cells. | ACS Nano | 2026 | 42361124 | PubTator, text mining | PubMed |
| Deciphering O‑GlcNAc-Dependent Signaling Via Integrated Proteomics and Phosphoproteomics. | ACS Omega | 2026 | 42326659 | PubTator, text mining | PubMed |
| Alphavirus nsP3 as a multifunctional orchestrator of virus-host interplay. | J Virol | 2026 | 42294907 | PubTator, text mining | PubMed |
CDCSI: a machine learning-based interpretable cell death and cellular senescence index for prognosis improvement, immune landscape characterization, and therapeutic response prediction in head and neck squamous cell carcinoma. | Front Immunol | 2026 | 42253970 | PubTator, text mining | PubMed |
| Discovery of BMS-159, an Orally Active Imidazotriazine Pan-CK2 Inhibitor for the Treatment of Cancer. | ACS Med Chem Lett | 2026 | 42157838 | PubTator, text mining | PubMed |
| Towards the targeted protein degradation of CK2: design and synthesis of CAM4066-based PROTACs. | Beilstein J Org Chem | 2026 | 42125065 | PubTator, text mining | PubMed |
| Inhibition of protein kinase CK2 remodels the tumor immune microenvironment and sensitizes lung cancer to PD-L1 blockade. | Exp Hematol Oncol | 2026 | 42106865 | PubTator, text mining | PubMed |
| CK2α Deficiency Drives Myocardial Fibrosis via Desmin-Induced Mitochondrial Dysfunction. | Adv Sci (Weinh) | 2026 | 42095508 | PubTator, text mining | PubMed |
| Autoantibodies Predictive of Atherosclerosis Progression and Statin Response in Juvenile-Onset SLE: A Biomarker Discovery Study. | medRxiv | 2026 | 42051571 | PubTator, text mining | PubMed |
| Functional characterization of 42 CK2α de novo variants associated with Okur-Chung neurodevelopmental syndrome. | FEBS J | 2026 | 41978434 | PubTator, text mining | PubMed |
| Protein arginine methyltransferases in cancer: mechanisms, functions, and therapeutic opportunities. | J Biomed Sci | 2026 | 41928257 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1459/papers